Find information on thousands of medical conditions and prescription drugs.

Hyperlipoproteinemia

Hyperlipoproteinemia is the presence of elevated levels of lipoprotein in the blood. Lipids (fatty molecules) are transported in a protein capsule, and the density of the lipids and type of protein determines the fate of the particle and its influence on metabolism. more...

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Although the terms hyperlipoproteinemia and hypercholesterolemia are often used interchangeably, the former is more specific. The term "hyperchylomicronemia" is used for an excess of chylomicrons.

Hyperlipoproteinemias are classified according to the Fredrickson/WHO classification (Fredrickson et al 1967), which is based on the pattern of lipoproteins on electrophoresis or ultracentrifugation.

Hyperlipoproteinemia type I

This very rare form (also known as "Buerger-Gruetz syndrome", "Primary hyperlipoproteinaemia", or "familial hyperchylomicronemia"), is due to high chylomicrons, the particles that transfer fatty acids from the digestive tract to the liver.

Hyperlipoproteinemia type II

Hyperlipoproteinemia Type II is hyperlipidemia (hypercholesterolemia) in the Fredrickson classification, which is determined by lipoprotein electrophoresis.

Hyperlipoproteinemia type II is further classified into:

  • Type IIa (elevated LDL only)
    • Polygenic hypercholesterolaemia
    • Familial hypercholesterolemia (FH)
  • Type IIb - combined hyperlipidemia (elevated LDL and VLDL, leading to high triglycerides levels)
    • Familial combined hyperlipoproteinemia
    • Secondary combined hyperlipoproteinemia

Hyperlipoproteinemia type III

This form is due to high chylomicrons and IDL (intermediate density lipoprotein).

Hyperlipoproteinemia type IV

This form is due to high triglycerides. It is also known as "hyperglyceridemia" (or "pure hyperglyceridemia".

Hyperlipoproteinemia type V

This type is very similar to Type I, but with high VLDL.

Unclassified forms

Non-classified forms are extremely rare:

  • Hypo-alpha lipoproteinemia
  • Hypo-beta lipoproteinemia

Read more at Wikipedia.org


[List your site here Free!]


Animal models of physical and social environmental stress - Extramurally Speaking …
From Environmental Health Perspectives, 9/1/02

The search to understand human health effects of environmental agents at all levels--molecular, cellular, organ, individual, and population--is hampered by a lack of specific model systems in which to carry out scientific investigations. In the past, assessment of potential adverse health effects of chemicals has been accomplished largely by tests utilizing laboratory animals. Both eukaryotic and prokaryotic cell culture models have been developed to elucidate molecular mechanisms by which physical and chemical environmental exposures activate or deregulate molecular pathways leading to disease outcomes. However, methods and models that can be employed to investigate how similar biological pathways are affected by exposures related to the social environment have not been as clearly defined.

The NIEHS is initiating programs that foster the use of animal models to study how social environmental stressors may activate or stimulate molecular pathways that can lead to disease states. Recent NIEHS scientific retreats have featured sessions on animal models of physical and social environmental stress (see, for example, "DERT Annual Scientific Retreat," EHP 110:A207 [2002], available online at http://ehpnet1.niehs.nih.gov/docs/2002/110-4/extram-speaking.html). Topics discussed during these sessions have included behavioral, neurochemical, and immunological effects of both social and physical stressors. For example, atherosclerosis induction by moderate hyperlipoproteinemia in group-housed cynomolgus macaques differs markedly in animals of dominant versus subordinate social status. Both rodent and primate studies reveal differential susceptibility to adenovirus infection and subsequent development of a biologically definable infection that is dependent on rank or social stature in the dominance hierarchy of the animal colonies. Such results suggest that social or psychosocial stress can affect immune function and lead to increased vulnerability to illness. These interactions may be crucial in addressing health problems associated with particular populations, such as individuals or communities of low socioeconomic status.

NIEHS-supported research assessing the contributions of the social environment (neighborhood characteristics, socioeconomic status, psychosocial stress, occupational hierarchy, race and gender discrimination, and social trust) has not focused on the use of animal models. The recent NIEHS-led trans-NIH solicitation ES-02-009, "Centers for Population Health and Health Disparities," is the first specific initiative that seeks to stimulate the use of animal models in investigating the contributions of social environmental factors to the activation of molecular pathways predisposing or leading to disease development. In addition, individual investigators are now actively encouraged to develop and utilize a variety of animal models to enhance our understanding of the biological and behavioral mechanisms by which both social and physical environmental influences can affect health status.

Contact:

Frederick Tyson I e-mail: tyson2@niehs.nih.gov Shobha Srinivasan I e-mai: sriniva2@niehs.nih.gov

COPYRIGHT 2002 National Institute of Environmental Health Sciences
COPYRIGHT 2004 Gale Group

Return to Hyperlipoproteinemia
Home Contact Resources Exchange Links ebay